Systemic lupus erythematosus (SLE), the embodiment of a multi-organ autoimmune disease, results from hyperactivation of host-defence pathways and immune recognition of the most fundamental building blocks of life. In 2018, key advances have placed intestinal immunity and dysregulated expansions of candidate pathobionts at the forefront of SLE pathogenesis.
12 days ago
The Microbiome and Systemic Lupus Erythematosus
12 days ago
Systemic Lupus Erythematosus and dysbiosis in the
microbiome: cause or effect or both?
12 days ago
“Non-criteria” antiphospholipid antibodies add value to antiphospholipid syndrome diagnoses in a large Chinese cohort
04.01.2021
Suppression of systemic lupus erythematosus in NZBWF1 mice infected with
Hymenolepis microstoma
04.01.2021
Precision Nutrition in Chronic Inflammation
17.12.2020
Thermoneutrality and Immunity: How Does Cold Stress Affect Disease?
17.12.2020
Soluble PD-1: Predictive, Prognostic,
and Therapeutic Value for Cancer
Immunotherapy
17.12.2020
The Tellurium-based Immunomodulator, AS101 Ameliorates Adjuvant-Induced Arthritis in Rats in Clinical & Experimental Immunology
14.12.2020
Infections are Associated With Increased Risk of Giant
Cell Arteritis: A Population-based Case-control Study from
Southern Sweden
07.12.2020